... and assess the ML/TF risks that may arise in relation to: (a) the development of new products and new business practices, including new delivery/distribution mechanisms; and (b) the use of new or developing technologies for both new and pre-existing products. Paragraph 2.10 9 Key AML/CFT Regulatory...

... and assess the ML/TF risks that may arise in relation to: (a) the development of new products and new business practices, including new delivery/distribution mechanisms; and (b) the use of new or developing technologies for both new and pre-existing products. Paragraph 2.10 9 Key AML/CFT Regulatory...

... from the Commissioner of Insurance dated 10th April 2006 which remains on the IA’s website, in relation to matters such as volume commission. It should also be noted that such additional measures for disclosure may also be required where remuneration from the insurer is in the form of commission that...

... from the Commissioner of Insurance dated 10th April 2006 which remains on the IA’s website, in relation to matters such as volume commission. It should also be noted that such additional measures for disclosure may also be required where remuneration from the insurer is in the form of commission that...

... 31-12-17 - - - - 中國人壽 China Life 31-12-17 63,073 176 10,424,768 999,573 太壽香港 TPLHK 31-12-17 1,518 - 2,611,557 - 安達人壽 Chubb Life 31-12-17 14,810 2 455,198 52,252 信諾環球人壽 CIGNA Worldwide Life 31-12-17 3,537 - 53,566 8,596 Desjardins Financial Security Desjardins Financial Security 31-12-17 - - - - 英國友誠國際...

... Framework”) I. Compliance with the CPD Requirements: Q1 – Q3 II. Reporting of CPD Compliance Records: Q4 – Q5 III. Imposition and Settlement of Pecuniary Fine: Q6 - Q7 IV. Waiver/Reduction of Penalty: Q8 V. Suspension or Revocation of Licence: Q9 – Q10 VI. Failure to submit or late in submitting the...

... decision-making. It may include a summary of key conclusions reached and the actions taken or planned that should be provided in the ORSA Report. The IA may also, on a need basis, request for the relevant minutes demonstrating the Board’s deliberations on main outcomes of the ORSA as mentioned in paragraph 10.2 of...